- LivaNova to Announce Second-Quarter 2024 Results
- LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
- LivaNova to Present at the Goldman Sachs Healthcare Conference
- LivaNova Reports First-Quarter 2024 Results
- LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
- LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
More ▼
Key statistics
On Monday, LivaNova PLC (LIVN:NSQ) closed at 54.26, -15.84% below its 52-week high of 64.48, set on May 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 52.91 |
---|---|
High | 54.50 |
Low | 52.78 |
Bid | 53.75 |
Offer | 54.69 |
Previous close | 52.91 |
Average volume | 791.80k |
---|---|
Shares outstanding | 54.15m |
Free float | 53.68m |
P/E (TTM) | -- |
Market cap | 2.95bn USD |
EPS (TTM) | -0.5911 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 21:00 BST.
More ▼